HIV-1 p24, His

HIV-1 p24 Recombinant, His Tag

Recombinantly produced in E. coli, the HIV-1 p24 His Tag protein is a single, non-glycosylated polypeptide chain consisting of 188 amino acids (residues 155-321). With a molecular weight of 21.2 kDa, it encompasses a 21 amino acid His Tag and is purified using standard chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT22470
Source
Escherichia Coli.
Appearance
A clear, sterile-filtered solution.

HIV-1 Polyvalent

HIV-1 Polyvalent Recombinant

Polyvalent HIV1 antigens contain HIV1 gp41 (long sequence) and new discovered HIV1 protein P30 from HIV1 genome.
Shipped with Ice Packs
Cat. No.
BT22867
Source

Escherichia Coli.

Appearance
Sterile Filtered clear solution.

HIV-1 Protease

HIV-1 Protease Recombinant

HIV-1 protease is a functional homodimer with a molecular weight of 21.6kDa. Each monomer consists of 99 amino acids and has a molecular weight of 10.8kDa.
Shipped with Ice Packs
Cat. No.
BT22951
Source
Escherichia Coli.
Appearance
The product is a clear, colorless solution that has been sterilized by filtration.

HIV-1 TAT Clade-A

HIV-1 TAT Clade-A Recombinant

HIV-1 TAT Clade-A Recombinant, produced in E.coli, is a single, non-glycosylated polypeptide chain with Accession number AAL06113.1.

Shipped with Ice Packs
Cat. No.
BT23041
Source
Escherichia Coli.
Appearance

While sterile filtered and lyophilized, it may appear as a solution due to the glycerol content.

HIV-1 TAT Clade-B

HIV-1 TAT Clade-B Recombinant

Recombinant HIV-1 TAT, synthesized in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 86 amino acids encoded by two exons and has a molecular weight of 14kDa.

Shipped with Ice Packs
Cat. No.
BT23127
Source
Escherichia Coli.
Appearance
While typically a sterile filtered and lyophilized powder, it might present as a solution due to the glycerol content.

HIV-1/2 ELISA

HIV-1/2 ELISA Recombinant

This product consists of paired HIV antigens, HIV1 gp41 and HIV2 gp36, intended for use in ELISA tests. These antigens are designed to identify antibodies against both HIV1 and HIV2 in patient samples. It's important to note that when placing an order, for instance, for 100µg of HIV-1/2 ELISA, you will receive 50µg of each antibody, totaling 100µg.

Shipped with Ice Packs
Cat. No.
BT23584
Source

Escherichia Coli.

Appearance

The product is supplied in two vials. Each vial contains a sterile, filtered solution that is clear and colorless.

HIV-1/2 Rapid

HIV-1/2 Rapid Test Recombinant

This product comprises HIV1 gp41 and HIV2 gp160 antibodies and is intended for use in developing sensitive and specific rapid tests for HIV. It is important to note that when placing an order, for instance, for 100µg of HIV-1/2 Rapid, we will dispatch 50µg of each antibody, totaling 100µg.

Shipped with Ice Packs
Cat. No.
BT23661
Source

Escherichia Coli.

Appearance

The product is supplied as two vials containing a sterile, filtered, clear, and colorless solution.

HIV-2 Envelope

HIV-2 Envelope Recombinant

The recombinant HIV-2 Envelope protein encompasses all known immunogenic determinants found in gp39. The gene encoding this fusion protein was synthesized using codons optimized for expression in Escherichia coli and does not represent a linear sequence of the native HIV-2 envelope protein. This non-glycosylated polypeptide chain consists of 135 amino acids, with a molecular weight of 16.127 kDa and an isoelectric point (pI) of 5.17.
Shipped with Ice Packs
Cat. No.
BT23742
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized by filtration.

HIV-2 gag

HIV-2 gag Recombinant

Recombinant HIV-2 gag protein, expressed in E. coli, consists of 231 amino acids with a molecular weight of 24kDa. This protein may appear as a dimer on SDS-PAGE gels. It is purified using a proprietary chromatographic method and has a purity greater than 90% as determined by 10% SDS-PAGE (Coomassie staining).
Shipped with Ice Packs
Cat. No.
BT23846
Source
Escherichia Coli.
Appearance
A clear, colorless, and sterile-filtered solution.

HIV-2 gp36

Synthetic HIV-2 gp36

HIV-2 gp36 is a chemically synthesized polypeptide that represents the full-length sequence of immunodominant regions within the HIV-2 envelope protein.
Shipped with Ice Packs
Cat. No.
BT24258
Source
Synthetic.
Appearance
The product appears as a clear, colorless solution that has been sterilized through filtration.
Definition and Classification

Human Immunodeficiency Virus (HIV) is a retrovirus that targets the immune system, specifically CD4+ T cells, leading to a progressive failure of the immune system and increased susceptibility to opportunistic infections and certain cancers . HIV is classified into two main types: HIV-1 and HIV-2. HIV-1 is the most prevalent and virulent form, responsible for the global pandemic, while HIV-2 is less transmissible and largely confined to West Africa .

Biological Properties

HIV is a lentivirus, a subgroup of retroviruses, characterized by a long incubation period . It primarily infects CD4+ T cells, macrophages, and dendritic cells . The virus is composed of two strands of RNA, 15 types of viral proteins, and a lipid bilayer membrane derived from the host cell . HIV is present in bodily fluids such as blood, semen, vaginal fluids, and breast milk .

Biological Functions

The primary function of HIV is to replicate within host cells. It targets CD4+ T cells, which play a crucial role in immune responses by coordinating the activity of other immune cells . By depleting these cells, HIV impairs the body’s ability to mount an effective immune response, leading to increased vulnerability to infections and diseases .

Modes of Action

HIV’s life cycle involves several stages: binding, fusion, reverse transcription, integration, replication, assembly, and budding . The virus binds to CD4 receptors on the host cell surface, fuses with the cell membrane, and releases its RNA into the cell. Reverse transcriptase converts viral RNA into DNA, which is then integrated into the host genome by integrase . The host cell machinery is used to produce viral proteins and RNA, which are assembled into new virions that bud off from the cell, ready to infect other cells .

Regulatory Mechanisms

HIV gene expression and latency are regulated by various mechanisms, including transcriptional regulation and post-transcriptional modifications . Long noncoding RNAs (lncRNAs) play a significant role in modulating HIV gene expression, acting as either activators or inhibitors . Epigenetic modifications, such as DNA methylation and histone modification, also influence viral transcription and latency .

Applications

HIV research has led to significant advancements in biomedical research, including the development of antiretroviral therapies (ART) that suppress viral replication and improve the quality of life for people living with HIV . HIV is also used as a model to study viral pathogenesis, immune responses, and the development of vaccines . Diagnostic tools, such as HIV antibody tests and nucleic acid tests, are crucial for early detection and management of the infection .

Role in the Life Cycle

HIV plays a critical role throughout its life cycle, from initial infection to the development of AIDS. The virus hijacks the host cell machinery to replicate and spread, leading to the gradual depletion of CD4+ T cells . Without treatment, HIV progresses through several stages: acute infection, chronic infection, and AIDS . Antiretroviral therapy can significantly slow this progression, allowing individuals to live longer, healthier lives .

© Copyright 2024 Thebiotek. All Rights Reserved.